The global short-acting beta-agonists market, crucial medications for treating asthma and COPD, is poised for substantial ...
GlobalData on MSN9d
AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trialA Phase III trial with the companies’ monoclonal antibody in patients with chronic rhinosinusitis with nasal polyps met its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback